The field of high dose rate (HDR) brachytherapy has witnessed rapid advances in optimisation techniques that aim to balance the dual imperatives of maximising tumour dose while minimising exposure to ...

A Technical Meeting on Patient Dose Monitoring and the Use of Diagnostic Reference Levels for the Optimization of Protection in Medical Imaging was held at the IAEA headquarters on 30 May - 3 June ...

Historically, anticancer drugs have been developed and approved for marketing on the basis of the assumption that the optimal dose is the maximum tolerated dose (MTD). That paradigm was well-suited ...

In a recent exclusive interview, Fierce Biotech’s Chris Hayden sat down with Alex MacDonald, Vice President of Model-Informed Drug Development at Allucent, to explore the impact of Project Optimus, an ...

Plus Therapeutics, Inc. has begun treating patients in its ReSPECT-LM dose optimization trial for REYOBIQ (rhenium Re186 obisbemeda), targeting leptomeningeal metastases (LM), a severe complication of ...